Refresh
Botanee Biotech (300957 CH) – ESOP Targets Stabilize Earnings Expectation
Despite a miss in 4Q, we think Botanee is set to recover along with China’s reopening, thanks to its OMO distribution network and an unchallenged...
CMB International
358 Views
Botanee Biotech (300957 CH) – A soft 3Q prompted for an earnings cut
3Q net profit was in line with both consensus and our estimates, although revenue was c.10%/5% below. Excluding non-core items, recurring net...
CMB International
111 Views
Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x
Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...
Sumeet Singh
272 Views
China Cosmetics – Key takeaway from 6.18 cosmetic sales
Our channel checks and various news sources we monitored suggests cosmetic GMV for 6.18 campaign this year stood at a small decline and reached...
CMB International
434 Views
China Consumer – From Reopening to Recovery
In other words, we believe the use of “excess saving” would predominantly kick-in upon a full-fledged consumption recovery.
CMB International
219 Views